Leandro Barile Agati

ORCID: 0000-0001-9655-4734 · 1 paper in corpus

other 2025

Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain

Annals of medicine ·doi:10.1080/07853890.2025.2527352

BACKGROUND: Pelvic pain secondary to endometriosis is a disabling condition. There are multiple treatments available, with variable endpoints. No prospective controlled studies were carried out evaluating subdermal pellets of gestrinone in …